Back to Search Start Over

Erratum. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 2016;39:139-148.

Authors :
Mita T
Katakami N
Yoshii H
Onuma T
Kaneto H
Osonoi T
Shiraiwa T
Kosugi K
Umayahara Y
Yamamoto T
Yokoyama H
Kuribayashi N
Jinnouchi H
Gosho M
Shimomura I
Watada H
Source :
Diabetes care [Diabetes Care] 2017 Jun; Vol. 40 (6), pp. 808. Date of Electronic Publication: 2017 Apr 18.
Publication Year :
2017

Details

Language :
English
ISSN :
1935-5548
Volume :
40
Issue :
6
Database :
MEDLINE
Journal :
Diabetes care
Publication Type :
Academic Journal
Accession number :
28420699
Full Text :
https://doi.org/10.2337/dc17-er06b